Credo Technology (CRDO) CTO's family trust sells 27,473 shares in plan trades
Rhea-AI Filing Summary
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported that the Cheng Huang Family Trust sold an aggregate of 27,473 ordinary shares on 2026-07-31 in multiple open-market or private transactions at weighted average prices between $201.2163 and $215.3500 per share. These sales were effected under a Rule 10b5-1 trading plan adopted by the trust on September 5, 2025. The shares are held by a family trust for which the reporting person and spouse are trustees, and he disclaims beneficial ownership beyond his and his spouse's pecuniary interest. He also reports 140,358 ordinary shares held directly.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 27,473 shares
Net Sell
14 txns
Insider
Cheng Chi Fung
Role
Chief Technology Officer
Sold
27,473 shs ($5.76M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2, F3 | 661 | $201.2163 | $133K |
| Sale | Ordinary Shares F1, F4, F3 | 139 | $202.2211 | $28K |
| Sale | Ordinary Shares F1, F5, F3 | 500 | $204.114 | $102K |
| Sale | Ordinary Shares F1, F6, F3 | 600 | $205.54 | $123K |
| Sale | Ordinary Shares F1, F7, F3 | 4,507 | $207.1051 | $933K |
| Sale | Ordinary Shares F1, F8, F3 | 4,093 | $208.0882 | $852K |
| Sale | Ordinary Shares F1, F9, F3 | 2,500 | $209.0779 | $523K |
| Sale | Ordinary Shares F1, F10, F3 | 3,700 | $210.1345 | $777K |
| Sale | Ordinary Shares F1, F11, F3 | 3,698 | $211.0932 | $781K |
| Sale | Ordinary Shares F1, F12, F3 | 4,306 | $212.1303 | $913K |
| Sale | Ordinary Shares F1, F13, F3 | 2,369 | $213.0386 | $505K |
| Sale | Ordinary Shares F1, F14, F3 | 200 | $213.835 | $43K |
| Sale | Ordinary Shares F1, F15, F3 | 200 | $215.35 | $43K |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 5,772,397 shares (Indirect, Cheng Huang Family Trust);
Ordinary Shares — 140,358 shares (Direct)
Footnotes (15)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 5, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $200.85 to $201.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. Represents ordinary shares held by the Cheng Huang Family Trust of which the Reporting Person and his spouse are trustees and the Reporting Person, his spouse and their children are beneficiaries. The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein. The full name of the trust is the Cheng Huang Family Trust U/T/A DTD 12/22/2003.
- F4. This transaction was executed in multiple trades at prices ranging from $202.07 to $202.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $203.80 to $204.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $205.18 to $205.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $206.54 to $207.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from 207.54 to $208.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $208.55 to $209.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. This transaction was executed in multiple trades at prices ranging from $209.63 to $210.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $210.63 to $211.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $211.64 to $212.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $212.68 to $213.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $213.77 to $213.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $215.06 to $215.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 27,473 ordinary shares
Lowest weighted average sale price: $201.2163 per share
Highest weighted average sale price: $215.3500 per share
+2 more
5 metrics
Shares sold
27,473 ordinary shares
Total non-derivative sales on 2026-07-31 by Cheng Huang Family Trust
Lowest weighted average sale price
$201.2163 per share
One of the reported open-market sales on 2026-07-31
Highest weighted average sale price
$215.3500 per share
One of the reported open-market sales on 2026-07-31
Direct holdings after transactions
140,358 ordinary shares
Directly held by Cheng Chi Fung as of 2026-07-31
Rule 10b5-1 plan adoption date
September 5, 2025
Trading plan governing Cheng Huang Family Trust sales
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, pecuniary interest, beneficial ownership
4 terms
Rule 10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
pecuniary interest financial
"disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest"
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider sale did Credo Technology (CRDO) report on this Form 4?
Credo reported that CTO and director Cheng Chi Fung, via the Cheng Huang Family Trust, sold 27,473 ordinary shares on 2026-07-31. The transactions were open-market or private sales executed in multiple trades at weighted average prices around $201–$215 per share.
Were the recent Credo (CRDO) insider sales made under a Rule 10b5-1 plan?
Yes. Footnotes state the reported sales were effected under a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 5, 2025. Such plans pre-schedule trades, which can reduce the informational significance of the exact timing of these sales.
Who actually executed the Credo (CRDO) insider sales reported for Cheng Chi Fung?
The transactions involve shares held by the Cheng Huang Family Trust, for which Cheng Chi Fung and his spouse are trustees. The footnote explains that he disclaims beneficial ownership of these shares except to the extent of his and his spouse's pecuniary interest in the trust.